Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M378Revenue $M7.9Net Margin (%)-541.5Z-Score1.3
Enterprise Value $M292EPS $-0.8Operating Margin %-546.7F-Score4
P/E(ttm))0Cash Flow Per Share $0.4Pre-tax Margin (%)-546.1Higher ROA y-yY
Price/Book3.910-y EBITDA Growth Rate %0Quick Ratio20.4Cash flow > EarningsY
Price/Sales48.75-y EBITDA Growth Rate %0Current Ratio20.4Lower Leverage y-yY
Price/Cash Flow6.4y-y EBITDA Growth Rate %0ROA % (ttm)-37.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-53.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.6ROI % (ttm)-48.7Gross Margin Increase y-yN

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJohn Hussman 2009-06-30 Sold Out -0.02%$4.53 - $6.84
($5.48)
$ 5.44-1%Sold Out0
PGNXJohn Hussman 2008-09-30 Buy 0.04%$12.19 - $17.07
($14.9)
$ 5.44-64%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broadfin Healthcare Master Fun10% Owner 2014-07-21Buy1,625,436$4.615.43 view
ISRAEL ROBERT JSenior VP Medical Affairs 2013-07-18Sell5,000$6.33-16.11 view
Baker Mark RobertCEO 2013-03-27Buy650$5.32-0.19 view
Baker Mark RobertCEO 2013-02-27Buy1,262$2.7295.22 view
Baker Mark RobertCEO 2013-01-22Buy1,215$2.8288.3 view
Baker Mark RobertCEO 2012-12-26Buy1,142$3.0176.41 view
Baker Mark RobertCEO 2012-11-28Buy1,607$2.13149.3 view
Baker Mark RobertCEO 2012-11-19Buy11,800$1.96170.92 view
Baker Mark RobertCEO 2012-11-16Buy49,793$1.82191.76 view
Baker Mark RobertCEO 2012-11-15Buy48,833$1.69214.2 view

Press Releases about PGNX :

    Quarterly/Annual Reports about PGNX:

    News about PGNX:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 26 2013 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
    Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
    5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
    Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
    Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Oct 04 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Sep 02 2010 

    More From Other Websites
    PROGENICS PHARMACEUTICALS INC Financials Aug 15 2014
    Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance Aug 12 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 11 2014
    FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR® Subcutaneous... Aug 11 2014
    FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR® Subcutaneous... Aug 11 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 08 2014
    Progenics Pharmaceuticals Announces Second Quarter 2014 Financial Results Aug 08 2014
    Progenics Pharmaceuticals Announces Second Quarter 2014 Financial Results Aug 08 2014
    Q2 2014 Progenics Pharmaceuticals Inc Earnings Release - Before Market Open Aug 08 2014
    Will Progenics (PGNX) Disappoint this Earnings Season? Aug 07 2014
    Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 8 Jul 31 2014
    Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 8 Jul 31 2014
    Key Stocks Seeing Insider Buying This Week Jul 26 2014
    Progenics (PGNX) Shares March Higher, Can It Continue? Jul 22 2014
    An Inefficient Stock Market Will Catch Up To Progenics Jul 21 2014
    Progenics-Salix Up on Encouraging Relistor News Jul 15 2014
    Biotechs, social stocks weak after Yellen warning Jul 15 2014
    Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% Jul 15 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 14 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK